Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameh K Morcos

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Opinion in Urology|December 5, 2006
Computed tomography urography technique, indications and limitationsSameh K Morcos
Quantitative Imaging in Medicine and Surgery|September 10, 2014
Can selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphadiesterase type 5 (PDE 5) offer protection against contrast induced nephropathy?Sameh K Morcos
Investigative Radiology|April 22, 2008
Validity of the animal models for nephrogenic systemic fibrosisSameh K Morcos
Radiologic Clinics of North America|September 12, 2009
Contrast-induced nephropathy and nephrogenic systemic fibrosis. PrefaceSameh K Morcos
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 14, 2006
Gadolinium-based contrast agents and nephrotoxicitySameh K Morcos
European Radiology|September 18, 2010
Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far?Sameh K Morcos
Journal of Vascular and Interventional Radiology : JVIR|January 11, 2005
Prevention of contrast media-induced nephrotoxicity after angiographic proceduresSameh K Morcos
NDT Plus|May 19, 2015
Comments on the case report reported by Elmholdt et alSameh K Morcos, Peter Dawson
World Journal of Radiology|December 24, 2010
Pathophysiology of nephrogenic systemic fibrosis: A review of experimental dataSameh K Morcos, John Haylor
AJR. American Journal of Roentgenology|May 23, 2007
Nephrogenic systemic fibrosis and nonionic linear chelatesHenrik S Thomsen, Sameh K Morcos
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Opinion in Urology|December 5, 2006
Computed tomography urography technique, indications and limitationsSameh K Morcos
Quantitative Imaging in Medicine and Surgery|September 10, 2014
Can selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphadiesterase type 5 (PDE 5) offer protection against contrast induced nephropathy?Sameh K Morcos
Investigative Radiology|April 22, 2008
Validity of the animal models for nephrogenic systemic fibrosisSameh K Morcos
Radiologic Clinics of North America|September 12, 2009
Contrast-induced nephropathy and nephrogenic systemic fibrosis. PrefaceSameh K Morcos
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 14, 2006
Gadolinium-based contrast agents and nephrotoxicitySameh K Morcos
European Radiology|September 18, 2010
Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far?Sameh K Morcos
Journal of Vascular and Interventional Radiology : JVIR|January 11, 2005
Prevention of contrast media-induced nephrotoxicity after angiographic proceduresSameh K Morcos
NDT Plus|May 19, 2015
Comments on the case report reported by Elmholdt et alSameh K Morcos, Peter Dawson
World Journal of Radiology|December 24, 2010
Pathophysiology of nephrogenic systemic fibrosis: A review of experimental dataSameh K Morcos, John Haylor
AJR. American Journal of Roentgenology|May 23, 2007
Nephrogenic systemic fibrosis and nonionic linear chelatesHenrik S Thomsen, Sameh K Morcos
Pageof 4